We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AOGO icon
201
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$2.42M 0.04%
226,579
– –
2022 Q2
5 quarters
ALCE
202
DELISTED
Alternus Clean Energy Inc
ALCE
$2.35M 0.04%
8,902
– –
2022 Q2
5 quarters
DXCM icon
203
DexCom
DXCM
$31.9B
$2.33M 0.04%
+25,000
New +$2.82M
2023 Q3
0 quarters
PODD icon
204
Insulet
PODD
$9.46B
$2.3M 0.04%
+14,400
New +$3.22M
2023 Q3
0 quarters
AXTA icon
205
Axalta
AXTA
$6.97B
$2.29M 0.04%
85,250
– –
2018 Q4
19 quarters
GOOGL icon
206
Alphabet (Google) Class A
GOOGL
$4.32T
$2.29M 0.04%
17,500
-9,500
-35% -$1.23M
2023 Q1
2 quarters
PTGX icon
207
Protagonist Therapeutics
PTGX
$9.63B
$2.27M 0.04%
136,268
+69,174
+103% +$1.34M
2022 Q1
6 quarters
TMCI icon
208
Treace Medical Concepts
TMCI
$255M
$2.27M 0.04%
173,004
+60,551
+54% +$1.11M
2022 Q1
6 quarters
FNVT icon
209
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.27M 0.04%
207,992
– –
2021 Q4
7 quarters
COLD icon
210
Americold
COLD
$3.93B
$2.27M 0.04%
74,510
-14,591
-16% -$472K
2022 Q4
3 quarters
AZEK icon
211
DELISTED
The AZEK Co
AZEK
$2.25M 0.04%
+75,800
New +$2.38M
2023 Q3
0 quarters
META icon
212
Meta Platforms (Facebook)
META
$1.87T
$2.25M 0.04%
7,500
-21,000
-74% -$6.33M
2023 Q1
2 quarters
ANAB icon
213
AnaptysBio
ANAB
$1.39B
$2.24M 0.04%
124,463
– –
2022 Q1
6 quarters
BNL icon
214
Broadstone Net Lease
BNL
$3.5B
$2.23M 0.04%
+155,900
New +$2.5M
2023 Q3
0 quarters
ZYME icon
215
Zymeworks
ZYME
$1.85B
$2.18M 0.04%
344,472
+25,000
+8% +$185K
2022 Q2
5 quarters
MFA icon
216
MFA Financial
MFA
$683M
$2.18M 0.04%
226,894
-78,968
-26% -$854K
2023 Q2
1 quarter
ARVN icon
217
Arvinas
ARVN
$492M
$2.16M 0.04%
110,182
+17,000
+18% +$417K
2023 Q1
2 quarters
ATRC icon
218
AtriCure
ATRC
$2.86B
$2.16M 0.04%
49,293
+9,000
+22% +$439K
2022 Q3
4 quarters
SWTX icon
219
DELISTED
SpringWorks Therapeutics
SWTX
$2.16M 0.04%
93,236
-22,397
-19% -$612K
2022 Q1
6 quarters
SPEC icon
220
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$2.14M 0.04%
192,601
– –
2022 Q1
6 quarters
ORIC icon
221
Oric Pharmaceuticals
ORIC
$1.24B
$2.13M 0.04%
351,502
-10,000
-3% -$81.9K
2022 Q2
5 quarters
CXM icon
222
Sprinklr
CXM
$1.32B
$2.08M 0.04%
150,000
-118,318
-44% -$1.69M
2023 Q1
2 quarters
IMCR icon
223
Immunocore
IMCR
$1.51B
$2.04M 0.04%
39,345
-1,000
-2% -$59.2K
2022 Q1
6 quarters
IRTC icon
224
iRhythm Holdings
IRTC
$3.48B
$1.99M 0.04%
21,158
+8,629
+69% +$877K
2023 Q1
2 quarters
HCMA icon
225
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$1.99M 0.04%
181,263
– –
2022 Q1
6 quarters
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.